drugset / Trial / NCT05663411
A Study of SHR6508 in Secondary Hyperparathyroidism
RandomizedParallel-groupOpen-labelTreatment
Summary
The study is being conducted to evaluate the efficacy and safety of SHR6508 for Chinese patients with secondary hyperparathyroidism of chronic kidney disease treated by maintenance hemodialysis.
Timeline
- Start
- 2023-02-24
- Primary completion
- 2023-10-31
- Completion
- 2023-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cinacalcet | Other / unclassified | — | — |
| Subject | SHR6508 | Unknown | — | — |